Atrial Fibrillation impacts a tremendous amount of people around the world and current treatment options are underwhelming due to negative side effects. FB–HRS, LLC has developed a treatment that may reduce those undesired consequences and successfully treat the condition. The next step is a clinical trial, in which the treatment’s viability will be assessed.

Read Full Press Release